Bentham Science Logo

Track Your Manuscript:


Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Letters in Drug Design & Discovery, Volume 13 - Number 3


Privileged 1,2,4-Oxadiazoles in Anticancer Drug Design: Novel 5- Aryloxymethyl-1,2,4-oxadiazole Leads for Prostate Cancer Therapy

, 13(3): 198 - 204

Alexey Lukin, Ruben Karapetian, Yan Ivanenkov and Mikhail Krasavin


DOI: 10.2174/1570180812999150812164251



Synthesis and Evaluation of Certain Symmetrical Schiff Bases as Inhibitors of MDA-MB-241 Human Breast Cancer Cell Proliferation

, 13(3): 205 - 209

Smaail Radi, Said Tighadouini, Olivier Feron, Olivier Riant and Yahia N. Mabkhot


DOI: 10.2174/1570180812999150812165510



Assembly of Quinoline, Triazole and Oxime Ether in a Single Molecular Entity: A Greener and One-pot Synthesis of Novel Oximes as Potential Cytotoxic Agents

, 13(3): 210 - 219

Koduru Sri Shanthi Praveena, Edupuganti Veera Venkat Shivaji Ramarao, Yedla Poornachandra, Chityal Ganesh Kumar, Nallapati Suresh Babu, Nandula Yadagiri Sreenivasa Murthy and Sarbani Pal


DOI: 10.2174/1570180812999150819095308



Synthesis and Properties of Brassinosteroid Biosynthesis Inhibitor Fluorescent Probe with Dansyl Moiety

, 13(3): 220 - 225

Tomoki Hoshi, Yuko Yoshizawa and Keimei Oh


DOI: 10.2174/1570180812999150812164840



Substituted 1,2,4-oxodiazoles as Potent Inhibitors of Human 11β - hydroxysteroid Dehydrogenase Type 1 (11β-HSD1): Virtual Screening and Docking Results

, 13(3): 226 - 233

Dmitry V. Ziolkovskiy, Victoria V. Lipson, Anastasia D. Nikitina and Valentin A. Chebanov


DOI: 10.2174/157018081303160212110319



Virtual Screening of NCI Diversity Set II Lead to New Cyclin-Dependent Kinases 5 Inhibitors Using AutoDock

, 13(3): 234 - 242

Siripit Pitchuanchom, Chavi Yenjai, Chantana Boonyarat, Stefano Forli and Arthur J. Olson


DOI: 10.2174/1570180812999150820161259



Flavonoids as Natural Inhibitors of Jack Bean Urease Enzyme

, 13(3): 243 - 249

Jalaluddin A. J. Awllia, Maryam AL-Ghamdi, Etimad Huwait, Sumaira Javaid, Atia-tul-Wahab, Saima Rasheed and M. Iqbal Choudhary


DOI: 10.2174/1570180812666150914220050



Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel Resistance

, 13(3): 250 - 254

Jingyu Chen and Michael Zhiyan Wang


DOI: 10.2174/1570180812666150730221941



Molecular Docking and Dynamics Simulation of Vibrio anguillarum Aspartate Semialdehyde Dehydrogenase with Natural Product Caulerpin

, 13(3): 255 - 261

Parasuraman Aiya Subramani, Radha Mahendran and Rajamani Dinakaran Michael


DOI: 10.2174/1570180812666150730221627



Peptide Drugs QSAR Modeling Based on a New Descriptor of Amino Acids- SVGT

, 13(3): 262 - 267

Jianbo Tong, Lingxiao Li, Shuling Liu and Jia Chang


DOI: 10.2174/1570180812999150819094745




Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)

Biography
View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog